Will de Groot
Will de Groot is a Managing Director of LS Associates, the interim C-Suite management arm of LifeSci Capital. Previously, Will was the Chief Business Officer of NKGen Biotech where he managed the funding process for the U.S. function of the Korean parent company. Will also successfully facilitated and negotiated two strategic partnerships with global biopharmaceutical companies for two separate clinical programs.
Prior to that operational role, Will as a Principal at Century City 1800/RSF Management, the Family Office of a successful private equity Founder/Partner, where he evaluated and lead deals and raised capital as necessary. While at RSF, Will also participated in the role of Principal at two private equity firms, Arrowhead Capital and Endurance Partners.
Will began his career in venture capital where he spent eight years a well-known venture capital fund where he progressed to Partner. He came to that venture capital firm having previously spent seven years in the biopharmaceutical industry working for GSK, Novartis and Millennium/Takeda.
Will holds a BA from La Salle University in Philadelphia, PA and an MBA from University of Chicago Booth School of Business.